Diagnosis and Treatment of Primary Biliary Cholangitis: A Patient-Friendly Summary of the 2018 AASLD Practice Guidance

Brian H. Horwich; Hyosun Han

doi:10.1002/cld.1158

Diagnosis and Treatment of Primary Biliary Cholangitis: A Patient-Friendly Summary of the 2018 AASLD Practice Guidance

Brian H. Horwich
, Hyosun Han

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	255-259
Number of pages	5
Journal	Clinical Liver Disease
Volume	18
Issue number	5
DOIs	https://doi.org/10.1002/cld.1158
State	Published - Nov 2021
Externally published	Yes

Access to Document

10.1002/cld.1158

Cite this

@article{f13c1081dd5b43f3a4f4cd48fec78282,

title = "Diagnosis and Treatment of Primary Biliary Cholangitis: A Patient-Friendly Summary of the 2018 AASLD Practice Guidance",

author = "Horwich, \{Brian H.\} and Hyosun Han",

note = "Funding Information: CLD would like to thank Cynthia Levy, M.D., author of the American Association for the Study of Liver Diseases (AASLD) PBC Practice Guideline, for her contributions to this Patient Page.",

year = "2021",

month = nov,

doi = "10.1002/cld.1158",

language = "English",

volume = "18",

pages = "255--259",

journal = "Clinical Liver Disease",

issn = "2046-2484",

publisher = "Wolters Kluwer Medknow Publications",

number = "5",

}

TY - JOUR

T1 - Diagnosis and Treatment of Primary Biliary Cholangitis

T2 - A Patient-Friendly Summary of the 2018 AASLD Practice Guidance

AU - Horwich, Brian H.

AU - Han, Hyosun

N1 - Funding Information: CLD would like to thank Cynthia Levy, M.D., author of the American Association for the Study of Liver Diseases (AASLD) PBC Practice Guideline, for her contributions to this Patient Page.

PY - 2021/11

Y1 - 2021/11

UR - https://www.scopus.com/pages/publications/85114715323

U2 - 10.1002/cld.1158

DO - 10.1002/cld.1158

M3 - Review article

AN - SCOPUS:85114715323

SN - 2046-2484

VL - 18

SP - 255

EP - 259

JO - Clinical Liver Disease

JF - Clinical Liver Disease

IS - 5

ER -